BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely low gestational age neonates

BACKGROUND: Extremely low gestational age neonates (ELGANs, i.e., neonates born before 28 weeks of gestation) are at high risk of developing retinopathy of prematurity (ROP), with potential long-life visual impairment. Due to concomitant anemia, ELGANs need repeated red blood cell (RBC) transfusions...

Descripción completa

Detalles Bibliográficos
Autores principales: Teofili, Luciana, Papacci, Patrizia, Orlando, Nicoletta, Bianchi, Maria, Pasciuto, Tina, Mozzetta, Iolanda, Palluzzi, Fernando, Giacò, Luciano, Giannantonio, Carmen, Remaschi, Giulia, Santosuosso, Michela, Beccastrini, Enrico, Fabbri, Marco, Valentini, Caterina Giovanna, Bonfini, Tiziana, Cloclite, Eleonora, Accorsi, Patrizia, Dragonetti, Antonella, Cresi, Francesco, Ansaldi, Giulia, Raffaeli, Genny, Villa, Stefania, Pucci, Giulia, Mondello, Isabella, Santodirocco, Michele, Ghirardello, Stefano, Vento, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746198/
https://www.ncbi.nlm.nih.gov/pubmed/36514106
http://dx.doi.org/10.1186/s13063-022-06949-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746198/
https://www.ncbi.nlm.nih.gov/pubmed/36514106
http://dx.doi.org/10.1186/s13063-022-06949-8

Ejemplares similares